Generated October 28, 2026 at 8:34 PM ET
· Covers October 28 trading day
· 10 of 368 ready 8-Ks selected
· AI-assisted overview
Across the selected 8-K filings, M&A was a major theme: First Community Bankshares (FCBC) agreed to acquire Main Street Financial Services in a $243 million stock merger, EnerSys agreed to acquire Ultralife (ULBI) for $16.00 per share in cash, and Curaleaf (CURLF) reiterated its case for its US$5.00-per-share Aurora bid. Regulatory items included Nasdaq’s denial of OSR Health’s appeal and delisting order for OSRH, FDA acceptance with Priority Review of Palvella’s (PVLA) QTORIN NDA, and a Nasdaq extension for Eureka Acquisition (EURK) to cure its public float deficiency. Beneficient (BENF) reported a Delaware Chancery motion seeking to void about $130 million of HCLP debt and recover about $211 million paid. Earnings filings included Amphenol (APH), Nextpower (NXT), and HF Sinclair (DINO), each reporting quarterly results and, in some cases, dividend or leadership updates.
regulatory
negative
materiality 0.80
October 28, 2026, 9:30 AM ET
Nasdaq panel denies OSR Health appeal, orders delisting; stock now quoted OTC as OSRH
- Panel decision dated Oct. 23, 2026 follows the Aug. 26, 2026 suspension of OSRH and OSRHW for failing Nasdaq's $1.00 minimum bid price rule.
- Company says it chose not to pursue a reverse stock split and will detail its plan to regain a national exchange listing on or before Nov. 6, 2026.
- $15 million equity put option with BCM Europe AG under the VXM01 license remains in place; as amended Oct. 15, 2026 it can settle via convertible notes at roughly $2.00-$5.00 per share.
FCBC
FIRST COMMUNITY BANKSHARES INC /VA/
M&A
positive
materiality 0.92
October 28, 2026, 8:53 AM ET
First Community Bankshares to acquire Main Street Financial Services in $243 million stock merger
- First Community (FCBC) agreed to acquire Main Street (MSWV) for 0.6174 FCBC shares per Main Street share, valued at about $30.14 per share and $243 million aggregate.
- Main Street reported $1.6 billion assets, $1.3 billion loans, $1.4 billion deposits and $137 million equity as of Sept. 30, 2026; combined assets expected near $5.2 billion.
- Main Street Bank operates 21 offices in east central Ohio and West Virginia's northern panhandle; the deal adds Ohio and expands First Community to five states.
PVLA
PALVELLA THERAPEUTICS, INC.
regulatory
positive
materiality 0.85
October 28, 2026, 7:30 AM ET
FDA accepts Palvella's QTORIN rapamycin NDA with Priority Review; PDUFA date Feb 28, 2027
- FDA accepted for filing and granted Priority Review to the NDA for QTORIN 3.9% rapamycin anhydrous gel in microcystic lymphatic malformations.
- PDUFA target action date set for February 28, 2027; if approved, would be the first FDA-approved therapy for microcystic LMs (>30,000 diagnosed in U.S.).
- Phase 3 SELVA met all six prespecified endpoints (all p<0.001); 95% of participants aged 6+ completing evaluation improved on the mLM-IGA primary endpoint.
CURLF
Curaleaf Holdings, Inc.
M&A
positive
materiality 0.75
October 28, 2026, 2:59 PM ET
Curaleaf says ASC ruling doesn't change case for US$5.00/share Aurora bid at 86% premium
- Curaleaf's enhanced offer implies ~US$5.00 per Aurora share, an 86% premium to Aurora's unaffected VWAP of ~US$2.75; Aurora calls it a discount.
- Curaleaf says Aurora sold ATM shares as low as US$2.56 — a 49% discount to the enhanced offer — less than a month before Curaleaf announced its bid.
- Aurora confirmed it stopped using its ATM program on August 18, 2026, shortly after Curaleaf challenged the activity, and has not used it since.
M&A
positive
materiality 0.95
October 28, 2026, 12:13 PM ET
EnerSys to acquire Ultralife for $16.00/share cash in ~$320M deal at 166% premium
- Ultralife shareholders will receive $16.00 per share in cash; transaction valued at approximately $320 million including assumption of net debt.
- Purchase price represents a 166% premium to Ultralife's closing stock price on October 26, 2026; both boards unanimously approved.
- Stockholders beneficially owning approximately 40.3% of Ultralife shares signed tender and support agreements to tender and vote for the merger.
litigation
positive
materiality 0.70
October 28, 2026, 7:45 AM ET
Beneficient moves to void ~$130M HCLP debt, recover $211M paid, citing Heppner fraud conviction
- Filed motion to intervene Oct 23, 2026 in Delaware Chancery suit HCLP Nominees v. Delaware Trust Company; proposed complaint seeks to invalidate HCLP credit agreements and cancel obligations.
- Success would eliminate roughly $130 million of purported HCLP debt, leaving the company with an unleveraged balance sheet; it also seeks return of ~$211 million already paid on the debt.
- Complaint draws on ex-CEO Brad Heppner's criminal trial evidence; convicted May 2026 of securities fraud and wire fraud, with sentencing rescheduled to January 11, 2027.
earnings
positive
materiality 0.88
October 28, 2026, 9:42 AM ET
Amphenol posts record Q3 2026 sales of $10.2B, raises dividend 20% and authorizes $4B buyback
- Q3 2026 sales $10.2B, up 65% y/y (37% organic); orders $12.2B for a 1.19:1 book-to-bill
- Adjusted diluted EPS $0.80, up 74%; GAAP EPS $0.79, up 61%; adjusted operating margin 29.7%
- Quarterly dividend raised 20% to $0.15 per share from $0.125, payable Jan 13, 2027 to holders of record Dec 22, 2026
EURK
Eureka Acquisition Corp
regulatory
negative
materiality 0.55
October 28, 2026, 4:30 PM ET
Eureka Acquisition wins Nasdaq extension to Jan 31, 2027 to cure public float deficiency
- Nasdaq notified Eureka Acquisition on Aug 27, 2026 that it failed Listing Rule 5450(a)(4) on minimum public float.
- Company submitted a compliance plan on Oct 12, 2026, the 45-day deadline; Nasdaq granted relief in a letter dated Oct 26, 2026.
- New deadline to regain compliance with the Public Float Rule is January 31, 2027; no delisting action announced.
earnings
positive
materiality 0.85
October 28, 2026, 4:06 PM ET
Nextpower Q2 FY27 revenue $1.109B, diluted EPS $1.08; backlog tops $6B
- Revenue rose to $1,109M from $905M a year earlier; GAAP net income $165M and diluted EPS $1.08 vs. $0.97 in Q2 FY26.
- Adjusted EBITDA was $250M (22.5% margin); Q2 FY27 results include about $99M of IRA 45X tax credit vendor rebates and tariffs, net.
- Backlog exceeded $6B on record quarterly bookings; eBOS bookings topped $100M and a 1.1 GW inverter framework agreement was signed.
earnings
positive
materiality 0.85
October 28, 2026, 6:32 AM ET
HF Sinclair Q3 net income jumps to $2,015M ($11.38/sh); $0.525 dividend; Ledbetter named CEO effective Jan 1, 2027
- Net income $2,015M, or $11.38/diluted share, vs $403M ($2.15) in Q3 2025; adjusted net income $2,079M, or $11.75/sh, vs $2.44.
- Refining income $2,435M vs $476M; adjusted refinery gross margin $54.22/bbl, up 183% YoY; crude charge 614,060 BPD vs 639,050 on El Dorado turnaround.
- Renewables income $123M vs -$55M on higher RINs prices and Producer's Tax Credit; Marketing $31M vs $22M; Lubricants $38M vs $52M after $109M Mississauga retirement costs.